Monitoring minimal residual disease (MRD) becomes increasingly important in the risk-adapted management of patients with acute myeloid leukemia (AML)...
Keywords: akute myeloische Leukämie (AML), minimale Resterkrankung (MRD), Multiparameter-Durchflusszytometrie (MFC), quantitative Real-time PCR (QRT-PCR)
10/2005 | LaboratoriumsMedizin, Walter de Gruyter